Saurabh Saha - 30 Sep 2023 Form 4 Insider Report for Centessa Pharmaceuticals plc (CNTA)

Role
Chief Executive Officer, Director
Signature
/s/ Gregory Weinhoff, attorney-in-fact
Issuer symbol
CNTA
Transactions as of
30 Sep 2023
Net transactions value
-$234,622
Form type
4
Filing time
03 Oct 2023, 16:53:01 UTC
Previous filing
03 Jul 2023
Next filing
02 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNTA Ordinary Shares Tax liability $234,622 -36,263 -4.2% $6.47 822,836 30 Sep 2023 Direct F1, F2
holding CNTA Ordinary Shares 38,000 30 Sep 2023 By trust F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted share units.
F3 These shares are held directly in a trust, for which the reporting person and his spouse serve as trustees.